Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. D'Haese, PC; Schrooten, I; Goodman, WG; Cabrera, WE; Lamberts, LV; Elseviers, MM; Couttenye, MM; De Broe, ME
   Increased bone strontium levels in hemodialysis patients with osteomalacia
   KIDNEY INTERNATIONAL
   
   P.C. D'Haese et al., "Increased bone strontium levels in hemodialysis patients with osteomalacia", KIDNEY INT, 57(3), 2000, pp. 1107-1114
2. Van Hoof, VO; Couttenye, MM; Van Brussel, KA; Wendelen, LC; Waegemans, SE; De Broe, ME
   Biochemical evaluation of bone metabolism in dialysis patients
   NIEREN-UND HOCHDRUCKKRANKHEITEN
   
   V.O. Van Hoof et al., "Biochemical evaluation of bone metabolism in dialysis patients", NIEREN HOCH, 28(10), 1999, pp. 402-406
3. Couttenye, MM; D'Haese, PC; Verschoren, WJ; Behets, GJ; Schrooten, I; De Broe, ME
   Low bone turnover in patients with renal failure
   KIDNEY INTERNATIONAL
   
   M.M. Couttenye et al., "Low bone turnover in patients with renal failure", KIDNEY INT, 56, 1999, pp. S70-S76
4. D'Haese, PC; Couttenye, MM; Lamberts, LV; Elseviers, MM; Goodman, WG; Schrooten, I; Cabrera, WE; De Broe, ME
   Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients
   CLINICAL CHEMISTRY
   
   P.C. D'Haese et al., "Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients", CLIN CHEM, 45(9), 1999, pp. 1548-1556
5. Couttenye, MM; D'Haese, PC; De Broe, ME
   What considerations should we give to adynamic bone disease?
   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
   
   M.M. Couttenye et al., "What considerations should we give to adynamic bone disease?", INT J ARTIF, 21(11), 1998, pp. 687-692
6. COUTTENYE MM; DHAESE PC; JURGENS A; PIESSENS A; LAMBRECHTS M; VERPOOTEN GA; DEBROE ME
   EXPOSURE TO EXTRACELLULAR IONIZED CALCIUM IN HEMODIALYSIS-PATIENTS WITH ADYNAMIC BONE-DISEASE AND HYPERPARATHYROID BONE-DISEASE
   Journal of the American Society of Nephrology
   
   M.M. Couttenye et al., "EXPOSURE TO EXTRACELLULAR IONIZED CALCIUM IN HEMODIALYSIS-PATIENTS WITH ADYNAMIC BONE-DISEASE AND HYPERPARATHYROID BONE-DISEASE", Journal of the American Society of Nephrology, 8, 1997, pp. 2560-2560
7. COUTTENYE MM; DHAESE PC; DENG JT; VANHOOF VO; VERPOOTEN GA; DEBROE ME
   HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION
   Nephrology, dialysis, transplantation
   
   M.M. Couttenye et al., "HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION", Nephrology, dialysis, transplantation, 12(10), 1997, pp. 2144-2150
8. SMANS KA; VANLANDEGHEM GF; DHAESE PC; COUTTENYE MM; DEBROE ME
   IS THERE A LINK BETWEEN ERYTHROPOIETIN THERAPY AND ADYNAMIC BONE-DISEASE
   Nephrology, dialysis, transplantation
   
   K.A. Smans et al., "IS THERE A LINK BETWEEN ERYTHROPOIETIN THERAPY AND ADYNAMIC BONE-DISEASE", Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1248-1249
9. COUTTENYE MM; DHAESE PC; VANHOOF VO; LEMONIATOU E; GOODMAN W; VERPOOTEN GA; DEBROE ME
   LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS
   Nephrology, dialysis, transplantation
   
   M.M. Couttenye et al., "LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 11(6), 1996, pp. 1065-1072
10. DHAESE PC; COUTTENYE MM; DEBROE ME
    DIAGNOSIS AND TREATMENT OF ALUMINUM BONE-DISEASE
    Nephrology, dialysis, transplantation
    
    P.C. Dhaese et al., "DIAGNOSIS AND TREATMENT OF ALUMINUM BONE-DISEASE", Nephrology, dialysis, transplantation, 11, 1996, pp. 74-79
11. EBO DG; DECLERCK LS; STEVENS WJ; IEVEN M; URSI D; VANGOETHEM JW; COUTTENYE MM
    HERPES-ZOSTER MYELITIS OCCURRING DURING TREATMENT FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    Journal of rheumatology
    
    D.G. Ebo et al., "HERPES-ZOSTER MYELITIS OCCURRING DURING TREATMENT FOR SYSTEMIC LUPUS-ERYTHEMATOSUS", Journal of rheumatology, 23(3), 1996, pp. 548-550
12. COUTTENYE MM; JURGENS A; LAMBERTS LV; VERPOOTEN GA; DHAESE PC; DEBROE ME
    DETERMINATION OF IONIZED CALCIUM - EVALUATION OF SAMPLING AND STORAGEPROCEDURES
    Clinical chemistry
    
    M.M. Couttenye et al., "DETERMINATION OF IONIZED CALCIUM - EVALUATION OF SAMPLING AND STORAGEPROCEDURES", Clinical chemistry, 42(3), 1996, pp. 468-469
13. DHAESE PC; LAMBERTS LV; COUTTENYE MM; GOODMAN WG; DEBROE ME
    BONE TRACE-METAL ALTERATIONS IN RENAL OSTEODYSTROPHY
    Journal of the American Society of Nephrology
    
    P.C. Dhaese et al., "BONE TRACE-METAL ALTERATIONS IN RENAL OSTEODYSTROPHY", Journal of the American Society of Nephrology, 6(3), 1995, pp. 934-934
14. DHAESE PC; COUTTENYE MM; LAMBERTS LV; GOODMAN WG; DEBROE ME
    INCREASED STRONTIUM LEVELS IN BONE OF DIALYSIS PATIENTS WITH OSTEOMALACIA
    Journal of the American Society of Nephrology
    
    P.C. Dhaese et al., "INCREASED STRONTIUM LEVELS IN BONE OF DIALYSIS PATIENTS WITH OSTEOMALACIA", Journal of the American Society of Nephrology, 6(3), 1995, pp. 935-935
15. DHAESE PC; COUTTENYE MM; GOODMAN WG; LEMONIATOU E; DIGENIS P; SOTORNIK I; FAGALDE A; BARSOUM RS; LAMBERTS LV; DEBROE ME
    USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD
    Nephrology, dialysis, transplantation
    
    P.C. Dhaese et al., "USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD", Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1874-1884
16. COUTTENYE MM; DEBROE ME
    LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS
    Nieren- und Hochdruckkrankheiten
    
    M.M. Couttenye e M.E. Debroe, "LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS", Nieren- und Hochdruckkrankheiten, 24(8), 1995, pp. 380-383
17. VANHOOF VO; MARTIN M; BLOCKX P; PROVE A; VANOOSTEROM A; COUTTENYE MM; DEBROE ME; LEPOUTRE LG
    IMMUNORADIOMETRIC METHOD AND ELECTROPHORETIC SYSTEM COMPARED FOR QUANTIFYING BONE ALKALINE-PHOSPHATASE IN SERUM
    Clinical chemistry
    
    V.O. Vanhoof et al., "IMMUNORADIOMETRIC METHOD AND ELECTROPHORETIC SYSTEM COMPARED FOR QUANTIFYING BONE ALKALINE-PHOSPHATASE IN SERUM", Clinical chemistry, 41(6), 1995, pp. 853-857
18. SMANS KA; DHAESE PC; LAMBERTS LV; VANLANDEGHEM GF; COUTTENYE MM; DEBROE ME
    UPTAKE OF ALUMINUM (AL) BY THE PARATHYROID CELLS (PTC) VIA TRANSFERRIN RECEPTOR (TFR)-MEDIATED ENDOCYTOSIS MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM IN ADYNAMIC BONE-DISEASE (ABD)
    Journal of the American Society of Nephrology
    
    K.A. Smans et al., "UPTAKE OF ALUMINUM (AL) BY THE PARATHYROID CELLS (PTC) VIA TRANSFERRIN RECEPTOR (TFR)-MEDIATED ENDOCYTOSIS MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM IN ADYNAMIC BONE-DISEASE (ABD)", Journal of the American Society of Nephrology, 5(3), 1994, pp. 889-889
19. DHAESE PC; COUTTENYE MM; LAMBERTS LV; GOODMAN WG; NUYTS GD; LEMONIATOU E; DIGENIS P; SOTORNIK I; FAGALDE A; DEBROE ME
    VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS
    Kidney international
    
    P.C. Dhaese et al., "VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS", Kidney international, 46(5), 1994, pp. 1461-1461
20. DEBROE ME; DHAESE PC; COUTTENYE MM; VANLANDEGHEM GF; LAMBERTS LV
    NEW INSIGHTS AND STRATEGIES IN THE DIAGNOSIS AND TREATMENT OF ALUMINUM OVERLOAD IN DIALYSIS PATIENTS
    Nephrology, dialysis, transplantation
    
    M.E. Debroe et al., "NEW INSIGHTS AND STRATEGIES IN THE DIAGNOSIS AND TREATMENT OF ALUMINUM OVERLOAD IN DIALYSIS PATIENTS", Nephrology, dialysis, transplantation, 8, 1993, pp. 47-50
21. VANUYTSEL JL; DHAESE PC; COUTTENYE MM; DEBROE ME
    HIGHER SERUM ALUMINUM CONCENTRATIONS IN IRON-DEPLETED DIALYSIS PATIENTS
    Nephrology, dialysis, transplantation
    
    J.L. Vanuytsel et al., "HIGHER SERUM ALUMINUM CONCENTRATIONS IN IRON-DEPLETED DIALYSIS PATIENTS", Nephrology, dialysis, transplantation, 7(2), 1992, pp. 177-177